Scabies in Emergency Medicine
- Author: Amy L McCroskey, MD; Chief Editor: Robert E O'Connor, MD, MPH more...
Background
Scabies is a common parasitic infection of global proportion. Worldwide, an estimated 300 million cases occur annually.[1] The arthropod Sarcoptes scabiei var hominis causes an intensely pruritic and highly contagious skin infestation,[2] which affects males and females of all socioeconomic status and ethnic groups. Scabies infestation has been reported for more than 2500 years. Aristotle discussed "lice in the flesh," which resulted in vesicles, and Celsus recommended sulfur mixed with liquid pitch as a remedy for the disease.[3] However, the disease was first ascribed to the mite by Giovan Cosimo Bonomo in 1687. It was the first human disease recognized to be caused by a specific pathogen.
Pathophysiology
Mode of transmission
Transmission of scabies is predominantly through direct skin-to-skin contact, and for this reason, scabies has been considered a sexually transmitted disease. Those at high risk include men who have sex with men and men with sexual contacts.[4] A person infested with mites can spread scabies even if he or she is asymptomatic.[1] There may be a prolonged interval (up to 10 wk) between the primary infection, when the patient becomes contagious, and the onset of clinical manifestations.[5] It is less frequently transmitted by indirect contact through fomites such as infested bedding or clothing. However, the greater the number of parasites on a person, as in crusted scabies, the more likely that indirect contact will transmit the disease.
The S scabiei var hominis mite that infects humans is female and can be seen with the naked eye (0.3-0.4 mm long). The male is about half this size. The mite has 4 pairs of legs. It does not penetrate deeper than the outer layer of the epidermis. Mites are unable to fly or jump. They crawl at a rate of 2.5 cm/min.[4] While the mite's life cycle occurs completely on its host, they are able to live on bedding, clothes, or other surfaces at room temperature for 2-3 days, while remaining capable of infestation and burrowing. At temperatures below 20°C, S scabiei are immobile, although they can survive such temperatures for extended periods.
Life cycle
The scabies mite is an obligate parasite and completes its entire life cycle on humans. Other variants of the scabies mite can cause infestation in other mammals such as dogs, cats, pigs, ferrets, and horses, and these variants can irritant human skin as well. However, they are unable to reproduce in humans and only cause a transient dermatitis.
Life cycle stages are as follows:[1]
- Eggs incubate and hatch in 3-4 days (90% of the hatched mites die).
- Larvae (3 pairs of legs) migrate to the skin surface and burrow into the intact stratum corneum to make short burrows, called molting pouches (3-4 d).
- Larvae molt into larger nymphs and then into adults.
- Mating takes place once, and the female is fertile for the rest of her life (1-2 mo), and the male dies soon after mating.
- She makes a serpentine burrow using proteolytic enzymes to dissolve the stratum corneum of the epidermis, laying eggs in the process, and she continues to lengthen her burrow and lay eggs for the rest of her life (1-2 mo).
- Transmission of impregnated females from person-to-person through direct or indirect skin contact.
Classic and Norwegian scabies
In classic scabies infection, anywhere from 5-15 mites (range, 3-50) live on the host.[4] Little evidence of infection exists during the first month (range, 2-6 wk), but after 4 weeks and with subsequent infections, a delayed-type IV hypersensitivity reaction to the mites, eggs, and scybala (packet of feces) occurs. The time required to induce immunity in primary infestations probably accounts for the latent period of 4 weeks of asymptomatic infection. In reinfestation, the sensitized individual may develop a rapid reaction (within hours). The resultant skin eruption, and its associated intense pruritus, is the hallmark of classic scabies. See the image below.
Scabies on the hand. Courtesy of William D. James, MD. Crusted, or Norwegian scabies (so named because the first description was from Norway in the mid 1800s), is a distinctive and highly contagious form of scabies. In this variant, hundreds to millions of mites infest the host individual, who is usually immunocompromised, elderly, or physically or mentally disabled and impaired.
Crusted scabies can be easily confused with severe dermatitis or psoriasis because widespread, crusted lesions appear with thick, hyperkeratotic scales over the elbows, knees, palms, and soles. The diagnosis of crusted scabies should be considered when suspected dermatitis or suspected psoriasis do not respond to usual treatments.[6] Serum immunoglobulin E (IgE) and immunoglobulin G (IgG) levels are extremely high in these patients, yet the immune reaction does not seem to be protective. Cell-mediated immunity in classic scabies demonstrates a predominantly CD4 T-cell infiltrate in the skin, while one study suggests a CD8 predominance in crusted scabies.
Atypical infestations may also befall the very young (neonates). See the image below.
Norwegian scabies. Courtesy of William D. James, MD. Epidemiology
Frequency
International
While many accounts of the epidemiology of scabies suggest that epidemics or pandemics occur in 30-year cycles, this may be an oversimplification of its incidence. These accounts coincided with the major wars of the 20th century. Because it is not a reportable disease, and data are based on variable notification, the incidence of scabies is difficult to ascertain.
Although epidemics have been reported (1919-1925, 1936-1949, 1964-1979), it is clearly an endemic disease in many tropical and subtropical regions. Scabies is 1 of the 6 major epidermal parasitic skin diseases (EPSD) that is prevalent in resource-poor populations, as reported in the Bulletin of the World Health Organization in February 2009.[7] Prevalence rates are extremely high in aboriginal tribes in Australia, Africa, South America,[8] and other developing regions of the world. Incidence in parts of Central America and South America and in one Indian village approach 100%. In parts of Bangladesh, the number of children with "the itch" exceeds the number with diarrheal and respiratory diseases combined.[7] In 2009 retrospective study of 30,078 children in India, scabies was found to be the second most common skin disease in all age groups of children, and the third most common skin disease in infants.[9]
Worldwide, the prevalence of scabies has been estimated at 300 million cases annually.[1, 10] In the United States and in other developed regions around the world, scabies occurs in epidemics in nursing homes, hospitals, long-term care facilities, and other institutions. It is seen frequently in the homeless populations but occurs episodically in other populations as well. No recent published data are available on its incidence in the United States. A study published in 2009 conducted in Brazil identified major risk factors for scabies in an impoverished rural community. The risk factors were young age, presence of many children in the household, illiteracy, low family income, poor housing, sharing clothes, and towels, and irregular use of showers.[11]
Mortality/Morbidity
Classic scabies is primarily a nuisance. However, it can indirectly lead to long-term morbidity. Scabies and other parasitic skin diseases can lead to long-term colonization of skin lesions by group A streptococci. Several studies have demonstrated a correlation between poststreptococcal glomerulonephritis (PSGN) and scabies. Conversely, in one World Health Organization sponsored study in the Solomon Islands, an intervention of mass treatment with ivermectin or permethrin led to a decrease in prevalence of scabies from 25% to less than 1% (p< 0.001) and a 40% to 20% decrease in pyoderma (secondary infection). There was also a decline in hematuria, which was a sign of renal damage by the group A Streptococcus secondary infection in children.[12] It also decreased occurrence of streptococcal skin disease.
In remote Aboriginal communities in Australia where scabies is endemic, the repeated infestations and secondary streptococcal infections appear to be related to the extremely high levels of renal failure and rheumatic heart disease observed in the communities.
While the microbiology of secondary bacterial infection in scabies lesions probably changes based on geographic location, one study demonstrated that the predominant aerobic and facultative bacteria recovered from lesions were Staphylococcus aureus, group A streptococci, and Pseudomonas aeruginosa. Multiple anaerobes were recovered as well, suggesting polymicrobial colonization of lesions.[13]
Other complications of scabies include impetigo, furunculosis, and cellulitis. The staphylococci or streptococci in the lesions can lead to pyelonephritis, poststreptococcal glomerulonephritis, abscesses, pyogenic pneumonia, sepsis, and death.
Scabies fact sheet. Atlanta. Centers for Disease Control and Prevention. 2005;[Full Text].
Rinnert K. Infectious diseases: Occupational exposures, infection control, and standard precautions. In: Tintinalli J, Kelen G, Stapczynski S, eds. Emergency Medicine: A Comprehensive Study Guide. 6th ed. New York: The McGraw-Hill Companies Inc; 2004:1005/13.
Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J. Jan 2005;81(951):7-11. [Medline].
Chosidow O. Clinical practices. Scabies. N Engl J Med. Apr 20 2006;354(16):1718-27. [Medline].
Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med. Feb 25 2010;362(8):717-25. [Medline].
Hay RJ. Scabies and pyodermas--diagnosis and treatment. Dermatol Ther. Nov-Dec 2009;22(6):466-74. [Medline].
Feldmeier H, Heukelbach J. Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues. Bull World Health Organ. Feb 2009;87(2):152-9. [Medline].
Heukelbach J, Wilcke T, Winter B, Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol. Jul 2005;153(1):150-6. [Medline].
Sardana K, Mahajan S, Sarkar R, et al. The spectrum of skin disease among Indian children. Pediatr Dermatol. Jan-Feb 2009;26(1):6-13. [Medline].
Hicks MI, Elston DM. Scabies. Dermatol Ther. Jul-Aug 2009;22(4):279-92. [Medline].
Feldmeier H, Jackson A, Ariza L, et al. The epidemiology of scabies in an impoverished community in rural Brazil: presence and severity of disease are associated with poor living conditions and illiteracy. J Am Acad Dermatol. Mar 2009;60(3):436-43. [Medline].
Lawrence G, Leafasia J, Sheridan J, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. Jan 2005;83(1):34-42. [Medline].
Brook I. Microbiology of secondary bacterial infection in scabies lesions. J Clin Microbiol. Aug 1995;33(8):2139-40. [Medline].
Scheinfeld N. Controlling scabies in institutional settings: a review of medications, treatment models, and implementation. Am J Clin Dermatol. 2004;5(1):31-7. [Medline].
Fliders DC, Schweinitz PD. Pediculosis and Scabies. Accessed May 24, 2009. American Family Physician, American Academy of Family Practice. Jan 15, 2004;[Full Text].
Schumann-Gable, N. Dermatology. In: Custer J, Rau R. The Johns Hopkins Hospital:The Harriet Lane Handbook. 8. 18th. Philadelphia, PA: Mosby Elevier; 2009:229-230.
Neynaber S, Wolff H. Diagnosis of scabies with dermoscopy. CMAJ. Jun 3 2008;178(12):1540-1. [Medline].
Hong MY, Lee CC, Chuang MC, Chao SC, Tsai MC, Chi CH. Factors related to missed diagnosis of incidental scabies infestations in patients admitted through the emergency department to inpatient services. Acad Emerg Med. Sep 2010;17(9):958-64. [Medline].
Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev. Jul 18 2007;CD000320. [Medline].
Hay RJ. Pyoderma and scabies: a benign association?. Curr Opin Infect Dis. Apr 2003;16(2):69-70. [Medline].
Cydulka RK, Hancock M. Dermatologic presentations. In: Marx JA, Hockberger RS, Walls RM, eds. Rosen's Emergency Medicine Concepts and Clinical Practice. Vol 2. 6th ed. Philadelphia, PA: Elsevier's Health Sciences; 2005:1854-1855/118.
Fraser V, Elward A. Infection control and isolation recommendations. In: Green G, Harris I, Lin G, Moylan K, eds. The Washington Manual of Medical Therapeutics. 363(9412). ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2004:675.
Feldmeier H, Singh Chhatwal G, Guerra H. Pyoderma, group A streptococci and parasitic skin diseases -- a dangerous relationship. Trop Med Int Health. Aug 2005;10(8):713-6. [Medline].
Burkhart CG. Scabies: an epidemiologic reassessment. Ann Intern Med. Apr 1983;98(4):498-503. [Medline].
Chosidow O. Clinical practices. Scabies. N Engl J Med. Apr 20 2006;354(16):1718-27. [Medline].
Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis. Jul 1 2004;39(1):e8-12. [Medline].
Dourmishev AL, Dourmishev LA, Schwartz RA. Ivermectin: pharmacology and application in dermatology. Int J Dermatol. Dec 2005;44(12):981-8. [Medline].
Elgart ML. Scabies. Dermatol Clin. Apr 1990;8(2):253-63. [Medline].
Epstein E, Orkin M. Orkin M, Maibach HI, Parish LC, eds. "Scabies: Clinical Aspects" in Scabies and Pediculosis. J.B. Lippincott: Schwartzman RM; 1977.
Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Scabies. In: Dermatology in General Medicine. 4th ed. McGraw-Hill: 1993:1812-1813.
Forrester MB, Sievert JS, Stanley SK. Epidemiology of lindane exposures for pediculosis reported to Poison Centers in Texas, 1998-2002. J Toxicol Clin Toxicol. 2004;42(1):55-60. [Medline].
Habif TP. Scabies. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 3rd ed. Mosby-Year Book; 1996:445-53.
Heukelbach J, Feldmeier H. Ectoparasites--the underestimated realm. Lancet. Mar 13 2004;363(9412):889-91. [Medline].
Kabrhel C, Binder W. Clinical pearls: a 37-year-old man with a rash... Acad Emerg Med. Jul 2003;10(7):776-9. [Medline].
Otero L, Varela JA, Espinosa E, et al. Sarcoptes scabiei in a sexually transmitted infections unit: a 15-year study. Sex Transm Dis. Dec 2004;31(12):761-5. [Medline].
Parish LC. Infection control and isolation recommendations. In: Orkin M, Maibach HI, Parish LC, eds. "History of Scabies" in Scabies and Pediculosis. Schwartzman RM: J.B. Lippincott; 1977:675.
Ramos-e-Silva M. Giovan Cosimo Bonomo (1663-1696): discoverer of the etiology of scabies. Int J Dermatol. Aug 1998;37(8):625-30. [Medline].
Schleicher SM, Stewart P. Scabies: The mite that roars. Emerg Med. 1997;6:54-8.
Walton SF, Holt DC, Currie BJ, Kemp DJ. Scabies: new future for a neglected disease. Adv Parasitol. 2004;57:309-76. [Medline].
Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis. Oct 15 2002;35:S146-51. [Medline].

